This symposium will equip you with the tools to confidently counsel without reinforcing harm, collaborate with the broader care team, and advocate for patients throughout their GLP-1 journey
10.1136/ard.2007.071936 22 MukhtyarC.LeeR.BrownD.CarruthersD.DasguptaB.DubeyS.et al (2009)
Belfort R, Harrison SA, Brown K, Darland C, Finch J, Hardies J, et al
By drug class , the GLP-1 receptor agonists segment led the market with an 80.1% revenue share in 2025 , owing to their proven effectiveness in weight reduction, appetite control, and long-term obesity management
Blood sugar spikes: GLP-1s help regulate glucose levels, so discontinuing the drug can cause blood sugar to rise, especially in people with Type 2 diabetes
40 , D370D376 (2012)